Illumina Delivery Order
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $700,000 to $1,500,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541380 Testing Laboratories and Services
- Points of contact
-
- Laquia Geathers laquia.geathers@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration is forecasting a new delivery order for Illumina reagents to support genomic sequencing activities across all four OAMT divisions. The contract is designed to facilitate bacterial and viral pathogen characterization for outbreak and surveillance sampling, with an estimated solicitation release date of December 1, 2025, and an anticipated award date of February 1, 2026. This opportunity falls under the Testing Laboratories and Services NAICS code 541380, with no specific set-aside designation.
While specific award values are not provided, the contract involves procuring Illumina reagents for pathogen research and testing purposes. The primary point of contact is Laquia Geathers (laquia.geathers@fda.hhs.gov) from the Food and Drug Administration, who can provide additional details about the procurement. The delivery order is scheduled to be posted on December 10, 2025, and will support critical genomic research and surveillance efforts across the agency's organizational units.
Forecast text
Illumina Delivery Order - in February (in support of Illumina activities across all four OAMT divisions) The Illumina reagents will be used for genomic sequencing and characterization of bacterial and viral pathogens associated with outbreak and surveillance sampling.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast